Nutritional Risk Status Predicts Overall Survival of Mexican Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Campos-Gomez, S. [1 ]
Valdez-Andrade, J. J. [1 ]
Esquivel-Gutierrez, J. [1 ]
Jaimes Alpizar, E. [1 ]
Pacheco-Cuellar, G. [1 ]
Campos-Gomez, K. [1 ]
机构：
[1] Ctr Oncol Estatal Issemym, Thorac Oncol Unit, Toluca De Lerdo, Mexico
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
nutrition risk; lung cancer; prognosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.11
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [31] Overall survival should be the primary endpoint in clinical trials for advanced non-small-cell lung cancer
    Cheema, P. K.
    Burkes, R. L.
    CURRENT ONCOLOGY, 2013, 20 (02) : E150 - E160
  • [32] Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
    Skrickova, Jana
    Bortlicek, Zbynek
    Hejduk, Karel
    Pesek, Milos
    Kolek, Vitezslav
    Tomiskova, Marcela
    Grygarkova, Ivona
    Koubkova, Leona
    Cernovska, Marketa
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Coupkova, Helena
    Satankova, Monika
    Marel, Milosalav
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [33] Non-small-cell lung cancer (NSCLC) treated with chemotherapy: Survival analysis of 50 patients
    Flores, MM
    Murillo, SM
    Alonso, EG
    Gilart, AB
    CarcellerVidal, JA
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1088 - 1088
  • [34] The association of nutritional and inflammatory biomarkers with overall survival in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors
    Horstman, I. M.
    Vinke, P. C.
    Suazo-Zepeda, E.
    Hiltermann, T. J. N.
    Heuvelmans, M. A.
    Corpeleijn, E.
    de Bock, G. H.
    THORACIC CANCER, 2024, 15 (23) : 1764 - 1771
  • [35] Association Between Baseline Tumor Diameters and Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Gerber, D. E.
    Dahlberg, S. E.
    Sandler, A. B.
    Perry, M. C.
    Schiller, J. H.
    Brahmer, J. R.
    Johnson, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S217 - S218
  • [36] Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Rogado, J.
    Pacheco-Barcia, V.
    Fenor De la Maza, M. D.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Obispo, B.
    Mondejar, R.
    Ballesteros, A.
    Donnay, O.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1915 - S1916
  • [37] Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non-Small-Cell Lung Cancer
    Davidoff, Amy J.
    Tang, Mei
    Seal, Brian
    Edelman, Martin J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2191 - 2197
  • [38] Breaking the Glass Ceiling of Overall Survival in Non-Small-Cell Lung Cancer
    Reinmuth, Niels
    Reck, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) : 1647 - +
  • [39] Clinically validated model predicts the effect of intratumoral heterogeneity on overall survival for non-small cell lung cancer (NSCLC) patients
    Ghaderi, Nima
    Jung, Joseph H.
    Odde, David J.
    Peacock, Jeffrey
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2021, 212
  • [40] HYDRAZINE SULFATE INFLUENCE ON NUTRITIONAL-STATUS AND SURVIVAL IN NON-SMALL-CELL LUNG-CANCER
    CHLEBOWSKI, RT
    BULCAVAGE, L
    GROSVENOR, M
    OKTAY, E
    BLOCK, JB
    CHLEBOWSKI, JS
    ALI, I
    ELASHOFF, R
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (01) : 9 - 15
12345